Dr. Reddy's Laboratories Limited (RDY) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 76.33B | 87.27B | 88.05B | 85.45B | 85.06B | 83.59B | 80.16B | 76.73B | 70.83B | 72.15B | 832.2M | 67.38B |
| Revenue Growth % | -10.26% | 4.41% | 9.84% | 11.37% | 20.09% | 15.85% | 9532.55% | 13.87% | 9151.62% | 6.57% | 5.33% | 29.2% |
| Cost of Goods Sold | 42.12B | 40.46B | 39.91B | 36.83B | 37.8B | 34.53B | 32.39B | 30.38B | 29.35B | 29.95B | 363.25M | 27.83B |
| COGS % of Revenue | 55.18% | 46.37% | 45.33% | 43.09% | 44.44% | 41.32% | 40.41% | 39.6% | 41.43% | 41.5% | 43.65% | 41.3% |
| Gross Profit | 34.22B | 46.81B | 48.14B | 48.63B | 47.26B | 49.05B | 47.77B | 46.34B | 41.48B | 42.2B | 468.95M | 39.55B |
| Gross Margin % | 44.82% | 53.63% | 54.67% | 56.91% | 55.56% | 58.68% | 59.59% | 60.4% | 58.57% | 58.49% | 56.35% | 58.7% |
| Gross Profit Growth % | -27.61% | -4.58% | 0.78% | 4.93% | 13.93% | 16.23% | 10086.48% | 17.17% | 9378.16% | 5.26% | 0.48% | 52.09% |
| Operating Expenses | 33.74B | 32.57B | 30.63B | 31.15B | 29.62B | 30.33B | 30.22B | 28.42B | 26.52B | 24.94B | 293.22M | 21.92B |
| OpEx % of Revenue | 44.2% | 37.32% | 34.78% | 36.46% | 34.82% | 36.29% | 37.7% | 37.04% | 37.45% | 34.56% | 35.23% | 32.53% |
| Selling, General & Admin | 28.19B | 26.92B | 26.44B | 23.18B | 24.05B | 24.12B | 23.01B | 22.69B | 20.48B | 20.23B | 227.34M | 0 |
| SG&A % of Revenue | 36.94% | 30.85% | 30.02% | 27.13% | 28.28% | 28.85% | 28.7% | 29.57% | 28.91% | 28.04% | 27.32% | - |
| Research & Development | 5.55B | 6.15B | 6.2B | 6.24B | 7.26B | 6.66B | 7.27B | 6.19B | 6.88B | 5.57B | 65.88M | 4.98B |
| R&D % of Revenue | 7.27% | 7.05% | 7.04% | 7.31% | 8.53% | 7.97% | 9.07% | 8.07% | 9.71% | 7.71% | 7.92% | 7.4% |
| Other Operating Expenses | 93 | -1000K | -1000K | 1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | 0 | 1000K |
| Operating Income | 473.25M | 14.24B | 17.51B | 17.48B | 17.65B | 18.72B | 17.55B | 17.93B | 14.96B | 17.27B | 175.72M | 17.64B |
| Operating Margin % | 0.62% | 16.32% | 19.89% | 20.45% | 20.75% | 22.4% | 21.89% | 23.36% | 21.12% | 23.93% | 21.12% | 26.17% |
| Operating Income Growth % | -97.32% | -23.94% | -0.22% | -2.51% | 17.97% | 8.41% | 9887.8% | 1.64% | 9634.42% | 5.13% | -11.34% | 44.42% |
| EBITDA | 6.14B | 19.29B | 22.56B | 22.24B | 22.2B | 23.44B | 21.53B | 21.73B | 18.67B | 21.04B | 221.55M | 21.2B |
| EBITDA Margin % | 8.04% | 22.1% | 25.63% | 26.03% | 26.1% | 28.04% | 26.85% | 28.33% | 26.36% | 29.16% | 26.62% | 31.47% |
| EBITDA Growth % | -72.36% | -17.71% | 4.82% | 2.32% | 18.9% | 11.42% | 9615.9% | 2.5% | 9601.92% | 6.81% | -6.66% | 38.94% |
| D&A (Non-Cash Add-back) | 5.66B | 5.05B | 5.05B | 4.76B | 4.55B | 4.72B | 3.98B | 3.81B | 3.71B | 3.77B | 45.83M | 3.57B |
| EBIT | 473.25M | 14.51B | 19.26B | 19.88B | 20.71B | 19.56B | 19.92B | 17.91B | 16.61B | 18.65B | 235.2M | 17.64B |
| Net Interest Income | 629.65M | 1.18B | 774M | 298M | -92M | -114M | -92M | 146M | 54M | 189M | 366M | -510.99K |
| Interest Income | 1.7B | 2.13B | 1.68B | 1.13B | 564M | 704M | 665M | 744M | 647M | 583M | 719M | 4M |
| Interest Expense | 1.07B | 951.84M | 907M | 830M | 656M | 818M | 757M | 598M | 593M | 394M | 353M | 4.51M |
| Other Income/Expense | 1.55B | 1.19B | 837M | 1.57B | 2.41B | 22M | 1.62B | 896M | 1.06B | 990M | 55.71M | 827M |
| Pretax Income | 2.02B | 15.43B | 18.35B | 19.05B | 20.05B | 18.74B | 19.17B | 18.82B | 16.02B | 18.26B | 231.44M | 18.46B |
| Pretax Margin % | 2.65% | 17.68% | 20.84% | 22.29% | 23.58% | 22.42% | 23.91% | 24.53% | 22.61% | 25.3% | 27.81% | 27.4% |
| Income Tax | -217.33M | 3.53B | 4.08B | 4.95B | 4.18B | 4.7B | 5.75B | 4.9B | 2.95B | 4.47B | 52.42M | 4.44B |
| Effective Tax Rate % | -10.75% | 22.9% | 22.25% | 25.99% | 20.85% | 25.1% | 30.01% | 26.04% | 18.39% | 24.47% | 22.65% | 24.04% |
| Net Income | 2.24B | 12.1B | 14.37B | 14.18B | 15.94B | 14.13B | 12.55B | 13.92B | 13.07B | 13.79B | 179.01M | 14.03B |
| Net Margin % | 2.93% | 13.86% | 16.32% | 16.59% | 18.74% | 16.91% | 15.66% | 18.14% | 18.45% | 19.11% | 21.51% | 20.81% |
| Net Income Growth % | -85.98% | -14.4% | 14.49% | 1.85% | 21.94% | 2.49% | 6912.29% | -0.75% | 11106.93% | 10.57% | 28.39% | 18.1% |
| Net Income (Continuing) | 2.24B | 11.9B | 14.27B | 14.1B | 15.87B | 14.04B | 13.41B | 13.92B | 13.07B | 13.79B | 179.01M | 14.03B |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 3.33B | 3.39B | 3.59B | 3.7B | 3.78B | 3.84B | 3.94B | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 2.68 | 14.52 | 17.25 | 17.02 | 19.10 | 16.94 | 15.05 | 16.69 | 15.67 | 16.54 | 17.76 | 84.22 |
| EPS Growth % | -85.97% | -14.29% | 14.62% | 1.98% | 21.89% | 2.42% | -15.26% | -80.18% | -72.8% | -77.93% | -73.45% | 17.96% |
| EPS (Basic) | 2.68 | 14.53 | 17.27 | 17.04 | 19.13 | 16.96 | 15.06 | 16.69 | 15.70 | 16.56 | 17.79 | 84.38 |
| Diluted Shares Outstanding | 834.8M | 833.2M | 833.02M | 833.02M | 834.3M | 834.3M | 834.11M | 833.93M | 833.95M | 833.88M | 833.52M | 832.64M |
| Basic Shares Outstanding | 834.8M | 833.2M | 832.04M | 832.04M | 833.31M | 833.31M | 833.62M | 833.93M | 832.57M | 832.57M | 831.83M | 831.05M |
| Dividend Payout Ratio | 1.84% | - | 46.33% | - | - | - | 53.07% | - | 0% | 0% | 3713.67% | - |